Lupin 2024

biological medicines

Pharmaceutical companies form Biosimilars Forum

WASHINGTON — A coalition of 11 biopharmaceutical companies has formed the Biosimilars Forum, described as the first nonprofit organization for expanding patient access to biosimilars in the United States. The group said Tuesday that its founding members represent the majority of companies with the most significant U.S. biosimilars development portfolios, including Actavis, Amgen, Boehringer Ingelheim,

PP_1170x120_10-25-21